Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
143
days
The Price of Speed: Estimating the Impact of List Prices on Time to Availability of New Medicines in 18 European Countries
Authors
Afschin GandjourShow moreShow less
Affiliations
1. Frankfurt School of Finance & Management, Frankfurt am Main, GermanyShow moreShow less
161
days
Deprescribing Interventions in Older Adults with Polypharmacy: A Systematic Review of Economic Evaluations
Authors
Josephine Aikpitanyi; Florence Pierrard; Catherine Pétein; Perrine Evrard; Anne Spinewine; Sandy TubeufShow moreShow less
Affiliations
1. Institute of Health and Society Research (IRSS), Faculty of Public Health, Université catholique de Louvain, Brussels, Belgium; 2. Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium; 3. Pharmacy Department, CHU UCL Namur, Université catholique de Louvain, Yvoir, BelgiumShow moreShow less
143
days
Causal Impact of Primary Care and Publicly Funded Health Insurance on Catastrophic Health Spending From Climate-Sensitive Diseases in India
Authors
Divya Chaudhary; Indranil MukhopadhyayShow moreShow less
Affiliations
1. Vivekananda School of Economics, Vivekananda Institute of Professional Studies-Technical Campus (VIPS-TC), Guru Gobind Singh Indraprastha University (GGSIPU), New Delhi, India; 2. Jindal School of Government and Public Policy, O. P. Jindal Global University, Sonipat, IndiaShow moreShow less
367
days
Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment
Authors
Thi Hao Pham; Susan de Braak; Sjoukje van der Werf; Sudewi Mukaromah Khoirunnisa; Xuanqi Pan; Andre Pfob; Abrham Wondimu; Jurjen van der Schans; Maarten J. Postma; Antoinette D. I. van Asselt; Lisa A. de JongShow moreShow less
Affiliations
1. Unit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 2. Health-Ecore Ltd, Zeist, The Netherlands; 3. Central Medical Library, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 4. Department of Pharmacy, Institut Teknologi Sumatera, Lampung Selatan, Indonesia; 5. Breast Center Heidelberg, Hospital St. Elisabeth, Heidelberg, Germany; 6. Department of Obstetrics and Gynecology, Heidelberg University Hospital, Heidelberg, Germany; 7. Department of Social and Administrative Pharmacy, University of Gondar, Gondar, Ethiopia; 8. Department of Strategic Management, Open University, Heerlen, The Netherlands; 9. Department of Economics, Econometrics and Finance, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands; 10. Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia; 11. Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; 12. Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsShow moreShow less
179
days
Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases
Authors
Fatemeh Hosseini; Mohammadreza Mobinizadeh; William V. PadulaShow moreShow less
Affiliations
1. Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK; 2. Health Management and Economics, National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Pharmaceutical and Health Economics, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, USC Schaeffer Center, Los Angeles, USA; 4. The Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, USA; 5. Stage Analytics, Suwanee, USAShow moreShow less
133
days
Structured Expert Elicitation of Long-Term Survival in Non-small Cell Lung Cancer: A Case Study Applying Guidance from NICE Technical Support Document 26
Authors
Jessica E. Forsyth; Monika Achra; Javier Baena Espinar; Maximilian Hochmair; Astra M. Liepa; Alan Lenox-Smith; Tarun Puri; Rahul Rajesh; Michael D. Sonksen; Yvonne Summers; Anthonie J. van der Wekken; Min-Hua Jen; Shijie RenShow moreShow less
Affiliations
1. Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, UK; 2. Eli Lilly and Company, Indianapolis, USA; 3. Hospital 12 de Octubre, Madrid, Spain; 4. Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria; 5. The Christie Hospital NHS Foundation Trust, Manchester, UK; 6. Department of Pulmonology and Tuberculosis, University of Groningen, University Medical Centre Groningen, Groningen, The NetherlandsShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days